FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090110 [Registered on: 03/07/2025] Trial Registered Prospectively
Last Modified On: 02/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Single Arm Study 
Public Title of Study   Prognostic ability of Hematocrit to Albumin ratio in Acute Pancreatitis Patient  
Scientific Title of Study   A Prospective Observational study on Prognostic ability of Hematocrit to Albumin ratio in Acute Pancreatitis Patient  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Arjun MH  
Designation  Junior resident 
Affiliation  Kasturba Medical College  
Address  Department of General Surgery,3rd floor smt.Sharadav Madhav Pai OPD, Kasturba Hospital, Manipal

Udupi
KARNATAKA
576104
India 
Phone  9962427778  
Fax    
Email  arjun1.kmcmpl2024@learner.manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr SS PRASAD  
Designation  Associate Dean Professor and Head of Department of General Surgery  
Affiliation  Kasturba Medical College  
Address  Department of General Surgery,3rd floor smt.Sharadav Madhav Pai OPD, Kasturba Hospital, Manipal

Udupi
KARNATAKA
576104
India 
Phone  8073680789  
Fax    
Email  Prasad.ss@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Arjun MH  
Designation  Junior resident 
Affiliation  Kasturba Medical College  
Address  Department of General Surgery,3rd floor smt.Sharadav Madhav Pai OPD, Kasturba Hospital, Manipal


KARNATAKA
576104
India 
Phone  9962427778  
Fax    
Email  arjun1.kmcmpl2024@learner.manipal.edu  
 
Source of Monetary or Material Support  
nil  
 
Primary Sponsor  
Name  DrArjun MH  
Address  Department of General Surgery,3rd floor , smt.Sharadav Madhav Pai OPD, Kasturba Hospital,Manipal-576104,Udupi District,Karnataka,INDIA  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
nil  nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Arjun MH   Kasturba Medical College and Hospital   3rd floor, Department of General Surgery, smt.Sharadav Madhav Pai OPD, Kasturba Hospital,Manipal-576104,Udupi District, Karnataka, INDIA
Udupi
KARNATAKA 
9962427778

arjun1.kmcmpl2024@learner.manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K85||Acute pancreatitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Patient diagnosed with acute pancreatitis based on the 2012 revised Atlanta Classification
Patient who provide informed consent to participate in the study  
 
ExclusionCriteria 
Details  Patient diagnosed with acute pancreatitis with significant unrelated complication (e.g. Nephrotic syndrome, CLD)
Patient with severe life threatening conditions (e.g.CKD STAGE 5,Malignancy)
Patient diagnosed with chronic pancreatitis or a history of recurrent pancreatitis  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Determine the relationship between Hematocrit to albumin ratio and severity of acute pancreatitis   1 years and 7 months  
 
Secondary Outcome  
Outcome  TimePoints 
Asses hematocrit to albumin ratio are associated with clinical outcomes, including complications and mortality rate.   1 years 7 months  
Analyze the incidence of complications(e.g., necrosis, infection, organ failure)in relation to the hematocrit to albumin ratio and insight their roles as potential biomarkers for complications.   1 year 7 months  
 
Target Sample Size   Total Sample Size="173"
Sample Size from India="173" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="9"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A Prospective Observational Study on Evaluating the Significance of the Hematocrit-to-Albumin Ratio in Predicting the Severity, Complications, and Prognosis of Acute Pancreatitis. The purpose of this study is to provide and simplify scoring systems for the prognosis of acute pancreatitis. The study is done between August 2025 to March 2027. Informed consent will be obtained from all willing participants, with minimal risk involved. For patients eligible under the inclusion criteria, the hematocrit-to-albumin values will be obtained. These investigations are routine and commonly investigated parameters. The hematocrit-to-albumin ratio shall be calculated and divided into two groups of high risk and low risk and shall be followed up to discharge. Sensitivity and specificity shall be calculated using the area under the curve, which helps to determine the relationship between the hematocrit-to-albumin ratio and the severity of acute pancreatitis 
Close